Gemmer Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-22
Closed 1409
2018
Q4
$0 Buy
22
+1
+5% +$18 ﹤0.01% 1381
2018
Q3
$0 Sell
21
-600
-97% -$11.9K ﹤0.01% 1423
2018
Q2
$12K Buy
621
+1
+0.2% +$19 ﹤0.01% 609
2018
Q1
$12K Hold
620
﹤0.01% 604
2017
Q4
$12K Buy
620
+601
+3,163% +$12K ﹤0.01% 626
2017
Q3
$0 Hold
19
﹤0.01% 1272
2017
Q2
$0 Hold
19
﹤0.01% 1255
2017
Q1
$0 Buy
+19
New +$352 ﹤0.01% 1237
2016
Q4
Sell
-18
Closed 1223
2016
Q3
$0 Buy
18
+1
+6% +$19 ﹤0.01% 1241
2016
Q2
$0 Buy
17
+1
+6% +$18 ﹤0.01% 1260
2016
Q1
$0 Hold
16
﹤0.01% 1263
2015
Q4
$0 Hold
16
﹤0.01% 1278
2015
Q3
$0 Hold
16
﹤0.01% 1286
2015
Q2
$0 Hold
16
﹤0.01% 1332
2015
Q1
$0 Buy
16
+1
+7% +$27 ﹤0.01% 1378
2014
Q4
$0 Buy
15
+1
+7% +$24 ﹤0.01% 1431
2014
Q3
$0 Hold
14
﹤0.01% 1439
2014
Q2
$0 Hold
14
﹤0.01% 1454
2014
Q1
$0 Buy
+14
New +$312 ﹤0.01% 1413

Other funds holding HQL

Gemmer Asset Management's HQL Position: Q1 2019 in Review

Gemmer Asset Management sold out of abrdn Life Sciences Investors (HQL) in Q1 2019, closing a stake of 22 shares.

Gemmer Asset Management first reported a position in HQL in Q1 2014 and held it in 19 quarters. The position peaked at $12K in Q2 2018. 56 funds tracked by Wall St. Rank hold HQL as of Q1 2019.

  • Gemmer Asset Management reported no remaining abrdn Life Sciences Investors position as of Q1 2019 after selling out during the quarter.
  • Gemmer Asset Management sold 22 abrdn Life Sciences Investors shares in Q1 2019.
  • Gemmer Asset Management first reported a position in abrdn Life Sciences Investors in Q1 2014 and held it in 19 quarters.
  • Gemmer Asset Management's abrdn Life Sciences Investors position peaked at $12K in Q2 2018.
  • 56 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2019.

Based on Gemmer Asset Management's 13F filing for Q1 2019, filed 17 Apr 2019.